Cited by 2,461Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsGeriatric Care and Nursing Homes

The DOI matches its Crossref record; 495 of the 496 references it cites were found in a registry or an index.

2019 Alzheimer’s disease facts and figures.

Alzheimer's Association·2019·Alzheimer's & Dementia

DOI 10.1016/j.jalz.2019.01.010

Open this paper in CoChat — free account

Abstract

This article describes the public health impact of Alzheimer's disease (AD), including incidence and prevalence, mortality and morbidity, use and costs of care, and the overall impact on caregivers and society. The Special Report examines the use of brief cognitive assessments by primary care physicians as a tool for improving early detection of dementia. An estimated 5.8 million Americans have Alzheimer's dementia. By mid‐century, the number of people living with Alzheimer's dementia in the United States may grow to 13.8 million, fueled in large part by the aging baby boom generation. In 2017, official death certificates recorded 121,404 deaths from AD, making AD the sixth leading cause of death in the United States and the fifth leading cause of death among Americans age ≥65 years. Between 2000 and 2017, deaths resulting from stroke, heart disease, and prostate cancer decreased, whereas reported deaths from AD increased 145%. In 2018, more than 16 million family members and other unpaid caregivers provided an estimated 18.5 billion hours of care to people with Alzheimer's or other dementias. This care is valued at nearly $234 billion, but its costs extend to family caregivers' increased risk for emotional distress and negative mental and physical health outcomes. Average per‐person Medicare payments for services to beneficiaries age ≥65 years with Alzheimer's or other dementias are more than three times as great as payments for beneficiaries without these conditions. Total payments in 2019 for health care, long‐term care and hospice services for people age ≥65 years with dementia are estimated to be $290 billion. Early detection of Alzheimer's offers numerous medical, emotional and financial benefits—benefits that accrue to affected individuals and their families as well as to society at large. Alzheimer's Association surveys regarding brief cognitive assessments for detection of dementia found that while a large majority of seniors and primary care physicians say the assessments are important, only half of seniors have received an assessment, and only 16 percent of seniors receive regular cognitive assessments. Many educational opportunities exist to facilitate increased use of brief cognitive assessments in the primary care setting.

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2019.01.010

Cites

495 of 495 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
ASSESSMENT OF COMA AND IMPAIRED CONSCIOUSNESS
Teasdale, G., & Jennett, B. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91639-0 · Cited by 13,215
Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
International Statistical Classification of Diseases and Related Health Problems
(2010) · Springer eBooks · doi:10.1007/978-0-387-79948-3_3055 · Cited by 4,182
What is cognitive reserve? Theory and research application of the reserve concept
STERN, Y. (2002) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617702813248 · Cited by 3,951
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786

Flagged first, then by citations

Show all 496 references

1 of the 496 references couldn’t be matched to a known paper.

Research works printed but not linked: 26

Grossberg GT, 2010, The art of sharing the diagnosis and management of Alzheimer's disease with patients and caregivers: Recommendations of an expert consensus panel, Prim Care Companion J Clin Psychiatry, 12
2015, Cognitive Aging: Progress in Understanding and Opportunity for Action
Sajeev G, Diabetes. The AlzRisk Database. Alzheimer Research Forum
Steptoe A, 2005, Aging, Health, and Public Policy
He W, 2016, International Population Reports, P95/16‐1, An Aging World: 2015
2006, Early‐Onset Dementia: A National Challenge, a Future Crisis
Manly JJ, 2004, Critical perspectives on racial and ethnic differentials in health in late life, 95
Prince MJ, 2015, World Alzheimer Report 2015: The Global Impact of Dementia: An Analysis of Prevalence
Ortman JM, 2014, An Aging Nation: The Older Population in the United States, Current Population Reports, P25‐1140
Heron M, 2018, Deaths: Leading causes for 2016
Kasper JD, 2014, Disability and Care Needs of Older Americans by Dementia Status: An Analysis of the 2011 National Health and Aging Trends Study
Maslow K, 2012, Translating Innovation to Impact: Evidence‐Based Interventions to Support People with Alzheimer's Disease and their Caregiver at Home and in the Community
Zarit SH, 2009, Aging families and caregiving, 131
Whitlatch CJ, 2018, Meeting the informational, educational, and psychosocial support needs of persons living with dementia and their family caregivers, Gerontologist, 58, S58
Khatutsky G, 2011, Understanding direct care workers: A snapshot of two of America's most important jobs: Certified nursing assistants and home health aides
Stone R, 2012, Universal Coverage of Long‐Term Care in the United States: Can We Get There from Here?, 155
Eldercare Workforce Alliance, 2012, Geriatrics Workforce Shortage: A Looming Crisis for our Families
National Academies of Sciences, 2016, Engineering, and Medicine. Families Caring for an Aging America
Eiken S, 2018, Medicaid Expenditures for Long‐Term Services and Supports in FY 2016. IAP Medicaid Innovation Accelerator Program
Bynum J, 2009, Unpublished; provided under contract with the Alzheimer's Association
Jacobson G, 2017, Income and Assets of Medicare Beneficiaries, 2016‐2035
National Association of Insurance Commissioners and the Center for Insurance Policy and Research, 2016, The State of Long‐Term Care Insurance: The Market, Challenges and Future Innovations
Reaves EL, 2015, Medicaid and Long‐Term Services and Supports: A Primer
10.1111/j.1525-1497.2005.0126.x · DOI
Albert SM, 2010, The MetLife Study of working caregivers and employer health care costs
Shriver M, 2010, The Shriver Report: A Woman's Nation Takes on Alzheimer's

Sorted by citations

Items 101–200 of 1,019

Genetic architecture of Alzheimer's disease
Neuner, S. M., TCW, J., & Goate, A. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104976 · Cited by 126
“Sex-specific genetic architecture AD is well-known to be more prevalent among elderly females, although it has been difficult to elucidate whether this is simply attributable to the longer lifespan of women (Alzheimer's Association, 2019; Arias et al., 2019).”
Background
Neuroimaging Modalities in Alzheimer’s Disease: Diagnosis and Clinical Features
Kim, J., Jeong, M., Stiles, W. R., & Choi, H. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116079 · Cited by 138
Long-term exposure to ambient air pollution, APOE-ε4 status, and cognitive decline in a cohort of older adults in northern Manhattan
Kulick, E. R., Elkind, M. S. V., Boehme, A. K., Joyce, N. R., Schupf, N., Kaufman, J. D., Mayeux, R. P., Manly, J. J., & Wellenius, G. A. (2020) · Environment International · doi:10.1016/j.envint.2019.105440 · Cited by 122
Conceptual Framework to Guide Intervention Research Across the Trajectory of Dementia Caregiving
Gallagher-Thompson, D. E., Bilbrey, A. C., Apesoa‐Varano, E. C., Ghatak, R., Kim, K. K., & Cothran, F. A. (2019) · The Gerontologist · doi:10.1093/geront/gnz157 · Cited by 127
The prevalence and incidence of early‐onset dementia among adults with autism spectrum disorder
Vivanti, G., Tao, S., Lyall, K., Robins, D. L., & Shea, L. (2021) · Autism Research · doi:10.1002/aur.2590 · Cited by 143
Neurovascular and immune mechanisms that regulate postoperative delirium superimposed on dementia
Wang, P., Velagapudi, R., Kong, C., Rodriguiz, R. M., Wetsel, W. C., Yang, T., Berger, M., Gelbard, H. A., Colton, C. A., & Terrando, N. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12064 · Cited by 120
Neuronal Network Excitability in Alzheimer’s Disease: The Puzzle of Similar versus Divergent Roles of Amyloid β and Tau
Kazim, S. F., Seo, J. H., Bianchi, R., Larson, C. S., Sharma, A., Wong, R. K. S., Gorbachev, K., & Pereira, A. C. (2021) · eNeuro · doi:10.1523/eneuro.0418-20.2020 · Cited by 120
Alzheimer’s Disease, Inflammation, and the Role of Antioxidants
Sinyor, B., Mineo, J., & Ochner, C. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200171 · Cited by 120
Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau
Rayaprolu, S., Higginbotham, L., Bagchi, P., Watson, C. M., Zhang, T., Levey, A. I., Rangaraju, S., & Seyfried, N. T. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-020-00840-3 · Cited by 118
Increased risk of incident dementia following use of anticholinergic agents: A systematic literature review and meta‐analysis
Dmochowski, R. R., Thai, S., Iglay, K., Enemchukwu, E., Tee, S., Varano, S., Girman, C. J., Radican, L., Mudd, P. N., & Poole, C. (2020) · Neurourology and Urodynamics · doi:10.1002/nau.24536 · Cited by 122
TLR4 Targeting as a Promising Therapeutic Strategy for Alzheimer Disease Treatment
Zhou, Y., Chen, Y., Xu, C., Zhang, H., & Lin, C. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.602508 · Cited by 120
Rural‐urban differences in diagnostic incidence and prevalence of Alzheimer's disease and related dementias
Rahman, M., White, E. M., Mills, C., Thomas, K. S., & Jutkowitz, E. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12285 · Cited by 121
Alzheimer's disease prediction using machine learning techniques and principal component analysis (PCA)
Sudharsan, M., & Thailambal, G. (2021) · Materials Today Proceedings · doi:10.1016/j.matpr.2021.03.061 · Cited by 130
Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials
Langbaum, J. B. S., Zissimopoulos, J., Au, R., Bose, N., Edgar, C. J., Ehrenberg, E., Fillit, H. M., Hill, C. V., Hughes, L., Irizarry, M. C., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12737 · Cited by 119
Multi-modal cross-attention network for Alzheimer’s disease diagnosis with multi-modality data
Zhang, J., He, X., Liu, Y., Cai, Q., Chen, H., & Qing, L. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107050 · Cited by 117
Detection of mild cognitive impairment and Alzheimer’s disease using dual-task gait assessments and machine learning
Ghoraani, B., Boettcher, L. N., Hssayeni, M. D., Rosenfeld, A., Tolea, M. I., & Galvin, J. E. (2021) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2020.102249 · Cited by 114
Alcohol drinking exacerbates neural and behavioral pathology in the 3xTg-AD mouse model of Alzheimer's disease
Hoffman, J. L., Faccidomo, S., Kim, M., Taylor, S. M., Agoglia, A. E., May, A. M., Smith, E. N., Wong, L. C., & Hodge, C. W. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.10.017 · Cited by 113
A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer’s Disease
Sun, M., Ma, K., Wen, J., Wang, G., Zhang, C., Li, Q., Bao, X., & Wang, H. (2020) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190872 · Cited by 113
Prevention of Early Alzheimer’s Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study
Li, I.-C., Chang, H., Lin, C., Chen, W.-P., Lu, T., Lee, L., Chen, Y., Chen, Y., Chen, C., & Lin, D. P. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00155 · Cited by 121
Effectiveness of Combined Cognitive and Physical Interventions to Enhance Functioning in Older Adults With Mild Cognitive Impairment: A Systematic Review of Randomized Controlled Trials
Yang, C., Moore, A. R., Mpofu, E., Dorstyn, D., Li, Q., & Yin, C. (2019) · The Gerontologist · doi:10.1093/geront/gnz149 · Cited by 120
The impact of dementia on the clinical outcome of COVID-19: a systematic review and meta-analysis
Liu, N., Sun, J., Wang, X., Zhao, M., Huang, Q., & Li, H. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-201016 · Cited by 110
Reactive Oxygen Species and Their Impact in Neurodegenerative Diseases: Literature Landscape Analysis
Yeung, A. W. K., Tzvetkov, N. T., Georgieva, M. G., Ognyanov, I., Kordos, K., Jóźwik, A., Kühl, T., Perry, G. L., Petralia, M. C., Mazzon, E., et al. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7952 · Cited by 112
Emerging Collaborative Care Models for Dementia Care in the Primary Care Setting: A Narrative Review
Heintz, H., Monette, P., Epstein-Lubow, G., Smith, L., Rowlett, S., & Forester, B. P. (2020) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.07.015 · Cited by 109
The Microbiome and Alzheimer’s Disease: Potential and Limitations of Prebiotic, Synbiotic, and Probiotic Formulations
Arora, K., Green, M., & Prakash, S. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.537847 · Cited by 115
A Primary Care Agenda for Brain Health: A Scientific Statement From the American Heart Association
Lazar, R. M., Howard, V. J., Kernan, W. N., Aparicio, H. J., Levine, D. A., Viera, A. J., Jordan, L. C., Nyenhuis, D. L., Possin, K. L., Sorond, F. A., et al. (2021) · Stroke · doi:10.1161/str.0000000000000367 · Cited by 109
Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer’s Disease
Parodi‐Rullán, R. M., Sone, J. Y., & Fossati, S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190357 · Cited by 110
Cognitively unimpaired adults’ reactions to disclosure of amyloid PET scan results
Largent, E. A., Harkins, K. A., van Dyck, C. H., Hachey, S. M., Sankar, P. L., & Karlawish, J. H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229137 · Cited by 112
Relation-induced multi-modal shared representation learning for Alzheimer’s disease diagnosis
Ning, Z., Xiao, Q., Feng, Q., Chen, W., & Zhang, Y. (2021) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2021.3063150 · Cited by 106
Rationale for Early Diagnosis of Mild Cognitive Impairment (MCI) supported by Emerging Digital Technologies
Sabbagh, M. N., Boada, M., Soo Borson, B., Chilukuri, M., Doraiswamy, P. M., Dubois, B., Ingram, J., Iwata, A., Porsteinsson, A. P., Possin, K. L., et al. (2020) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2020.19 · Cited by 111
Chatbots to Support People With Dementia and Their Caregivers: Systematic Review of Functions and Quality
Ruggiano, N., Brown, E. L., Roberts, L., Framil Suarez, C. V., Luo, Y., Hao, Z., & Hristidis, V. (2021) · Journal of Medical Internet Research · doi:10.2196/25006 · Cited by 100
“This can have a negative impact on the quality of care and outcomes for people with dementia [31].”
Influential
Integrated network pharmacology analysis and serum metabolomics to reveal the cognitive improvement effect of Bushen Tiansui formula on Alzheimer's disease
Zhang, Z., Yi, P., Yang, J., Huang, J., Xu, P., Hu, M., Zhang, C., Wang, B., & Peng, W. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112371 · Cited by 105
Alzheimer’s Disease: Etiology, Neuropathology and Pathogenesis
Sheppard, O., & Coleman, M. P. (2020) · Exon Publications eBooks · doi:10.36255/exonpublications.alzheimersdisease.2020.ch1 · Cited by 127
Association between blood pressure and later-life cognition among black and white individuals
Levine, D. A., Gross, A. L., Briceño, E. M., Tilton, N., Kabeto, M. U., Hingtgen, S. M., Giordani, B. J., Sussman, J. B., Hayward, R. A., Burke, J. F., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.0568 · Cited by 103
MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties
Chopra, N., Wang, R., Maloney, B., Nho, K. T., Beck, J. S., Pourshafie, N., Niculescu, A. B., Saykin, A. J., Rinaldi, C., Counts, S., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0610-2 · Cited by 101
Classifying Alzheimer's Disease Using Audio and Text-Based Representations of Speech
Haulcy, R., & Glass, J. R. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.624137 · Cited by 110
Brain‐Penetration and Neuron‐Targeting DNA Nanoflowers Co‐Delivering miR‐124 and Rutin for Synergistic Therapy of Alzheimer's Disease
Ouyang, Q., Liu, K., Zhu, Q., Deng, H., Le, Y., Ouyang, W., Yan, X., Zhou, W., & Tong, J. (2022) · Small · doi:10.1002/smll.202107534 · Cited by 94
Cascaded multi-modal mixing transformers for Alzheimer’s disease classification with incomplete data
Liu, L., Liu, S., Zhang, L., To, X. V., Nasrallah, F., & Chandra, S. S. (2023) · NeuroImage · doi:10.1016/j.neuroimage.2023.120267 · Cited by 101
Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research
Dennison, J. L., Ricciardi, N. R., Lohse, I., Volmar, C., & Wahlestedt, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201014 · Cited by 107
Implications of microbe-derived ɣ-aminobutyric acid (GABA) in gut and brain barrier integrity and GABAergic signaling in Alzheimer’s disease
Conn, K. A., Borsom, E. M., & Cope, E. K. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2371950 · Cited by 106
“50,52 While each of these symptoms are common manifestations of aging, even in healthy individuals, patients living with AD experience these symptoms at greater severities than what would be expected for their age.”
BackgroundInfluential
Detection of Mild Cognitive Impairment Using Convolutional Neural Network: Temporal-Feature Maps of Functional Near-Infrared Spectroscopy
Yang, D., Huang, R., Yoo, S.-H., Shin, M., Yoon, J. A., Shin, Y., & Hong, K. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00141 · Cited by 98
Evidence for exercise-related plasticity in functional and structural neural network connectivity
Won, J., Callow, D. D., Pena, G. S., Gogniat, M. A., Kommula, Y., Arnold-Nedimala, N. A., Jordan, L. S., & Smith, J. C. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.10.013 · Cited by 109
Alzheimer’s disease: A clinical perspective and future nonhuman primate research opportunities
Haque, R. U., & Levey, A. I. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912954116 · Cited by 99
Development and Validation of eRADAR: A Tool Using EHR Data to Detect Unrecognized Dementia
Barnes, D. E., Zhou, J., Walker, R. L., Larson, E. B., Lee, S. J., Boscardin, W. J., Marcum, Z. A., & Dublin, S. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16182 · Cited by 94
Alzheimer’s disease diagnosis from diffusion tensor images using convolutional neural networks
Marzban, E. N., Eldeib, A. M., Yassine, I. A., Kadah, Y. M., & Initiative, A. D. N. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230409 · Cited by 104
Synaptic plasticity in Alzheimer’s disease and healthy aging
Torres, D. M. C., & Cárdenas, F. P. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0058 · Cited by 101
Assessment of Rural-Urban Differences in Health Care Use and Survival Among Medicare Beneficiaries With Alzheimer Disease and Related Dementia
Rahman, M., White, E. M., Thomas, K. S., & Jutkowitz, E. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.22111 · Cited by 98
Individual brain metabolic connectome indicator based on Kullback-Leibler Divergence Similarity Estimation predicts progression from mild cognitive impairment to Alzheimer’s dementia
Wang, M., Jiang, J., Yan, Z., Alberts, I., Ge, J., Zhang, H., Zuo, C., Yu, J., Rominger, A., Shi, K., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04814-x · Cited by 98
Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer’s disease: Past, present and future
Gouveia, F., Camins, A., Ettcheto, M., Bicker, J., Falcão, A. C., Cruz, M. T., & Fortuna, A. C. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101612 · Cited by 99
A Deep Learning-Based Ensemble Method for Early Diagnosis of Alzheimer’s Disease using MRI Images
Fathi, S., Ahmadi, A., Dehnad, A., Almasi‐Dooghaee, M., Sadegh, M., & Initiative, A. D. N. (2023) · Neuroinformatics · doi:10.1007/s12021-023-09646-2 · Cited by 98
“The death rate of heart disease and prostate cancer has decreased in the last two decades; meantime, the death rate of AD has increased by 145 percent, making AD the sixth leading cause of death in the US (Association, 2019; Basheer et al., 2021; Nawaz et al., 2021).”
Automatic dementia screening and scoring by applying deep learning on clock-drawing tests
Chen, S., Stromer, D., Alabdalrahim, H. A., Schwab, S., Weih, M., & Maier, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-74710-9 · Cited by 99
A Deep Learning approach for Diagnosis of Mild Cognitive Impairment Based on MRI Images
Gorji, H. T., & Kaabouch, N. (2019) · Brain Sciences · doi:10.3390/brainsci9090217 · Cited by 101
Machine Learning and Image Processing Enabled Evolutionary Framework for Brain MRI Analysis for Alzheimer’s Disease Detection
Kamal, M., Pratap, A., Naved, M. I., Zamani, A. S., Nancy, P., Ritonga, M., Shukla, S. K., & Sammy, F. (2022) · Computational Intelligence and Neuroscience · doi:10.1155/2022/5261942 · Cited by 95
Retracted
Application of Artificial Intelligence techniques for the detection of Alzheimer’s disease using structural MRI images
Zhao, X., Ang, C. K. E., Acharya, U. R., & Cheong, K. H. (2021) · Journal of Applied Biomedicine · doi:10.1016/j.bbe.2021.02.006 · Cited by 96
Caregiving Burden Among Caregivers of People With Dementia Through the Lens of Intersectionality
Liu, R., Chi, I., & Wu, S. (2022) · The Gerontologist · doi:10.1093/geront/gnab146 · Cited by 92
Estimates of the Association of Dementia With US Mortality Levels Using Linked Survey and Mortality Records
Stokes, A. C., Weiss, J., Lundberg, D. J., Xie, W., Kim, J. K., Preston, S. H., & Crimmins, E. M. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.2831 · Cited by 94
Immunotherapies for Aging-Related Neurodegenerative Diseases—Emerging Perspectives and New Targets
Kwon, S., Iba, M., Kim, C., & Masliah, E. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00853-2 · Cited by 97
tRNA-Derived Fragments in Alzheimer’s Disease: Implications for New Disease Biomarkers and Neuropathological Mechanisms
Wu, W., Lee, I., Spratt, H. M., Fang, X., & Bao, X. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200917 · Cited by 94
The Longitudinal Early‐onset Alzheimer's Disease Study (LEADS): Framework and methodology
Apostolova, L. G., Aisen, P. S. S., Eloyan, A., Fagan, A. M., Fargo, K. N., Foroud, T., Gatsonis, C. A., Grinberg, L. T., Jack, C. R., Kramer, J. H., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12350 · Cited by 93
The neurobiology of non-coding RNAs and Alzheimer’s disease pathogenesis: Pathways, mechanisms and translational opportunities
Lauretti, E., Dabrowski, K. R., & Praticò, D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101425 · Cited by 97
A systematic review of cognitive event-related potentials in mild cognitive impairment and Alzheimer’s disease
Paitel, E. R., Samii, M. R., & Nielson, K. A. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112904 · Cited by 95
The Bidirectional Relationship between Vision and Cognition
Vu, T. A., Fenwick, E., Gan, A. T. L., Man, R. E. K., Tan, B. K. J., Gupta, P., Ho, K. C., Ortiz, C. A. R., Trompet, S., Gussekloo, J., et al. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2020.12.010 · Cited by 97
Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer's Disease
Kellar, D., Lockhart, S. N., Aisen, P. S. S., Raman, R., Rissman, R. A., Brewer, J. B., & Craft, S. (2021) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2021.14 · Cited by 92
Linking mechanisms of periodontitis to Alzheimer's disease
Sadrameli, M., Bathini, P., & Alberi, L. A. (2020) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000797 · Cited by 93
Results of a Randomized Trial Testing the Efficacy of Tele-Savvy, an Online Synchronous/Asynchronous Psychoeducation Program for Family Caregivers of Persons Living with Dementia
Hepburn, K. W., Nocera, J. R., Higgins, M. K., Epps, F. R., Brewster, G. S., Lindauer, A., Morhardt, D., Shah, R. C., Johnson, K. B., Nash, R. J., et al. (2021) · The Gerontologist · doi:10.1093/geront/gnab029 · Cited by 93
The association of epigenetic clocks in brain tissue with brain pathologies and common aging phenotypes
Grodstein, F., Lemos, B., Yu, L., Klein, H., Iatrou, A., Buchman, A. S., Shireby, G. L., Mill, J. S., Schneider, J. A., Jager, P. L. D., et al. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105428 · Cited by 89
Artificial Intelligence for Cognitive Health Assessment: State-of-the-Art, Open Challenges and Future Directions
Javed, A. R., Saadia, A., Mughal, H., Gadekallu, T. R., Rizwan, M., Maddikunta, P. K. R., Mahmud, M., Liyanage, M., & Hussain, A. (2023) · Cognitive Computation · doi:10.1007/s12559-023-10153-4 · Cited by 99
“Forecasts suggest that early diagnosis in the MCI stage in the year 2050 can bring health care costs down by $231 billion [5].”
Background
The NLRP3 Inflammasome as a Critical Actor in the Inflammaging Process
Sebastian-Valverde, M., & Pasinetti, G. M. (2020) · Cells · doi:10.3390/cells9061552 · Cited by 90
Development of Near-Infrared Fluorescent Probes for Use in Alzheimer’s Disease Diagnosis
Yang, J., Zeng, F., Ge, Y., Peng, K., Li, X., Li, Y., & Xu, Y. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00695 · Cited by 87
Brain-specific repression of AMPKα1 alleviates pathophysiology in Alzheimer’s model mice
Zimmermann, H. R., Yang, W., Kasica, N. P., Zhou, X., Wang, X., Beckelman, B. C., Lee, J., Furdui, C. M., Keene, C. D., & Ma, T. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133982 · Cited by 86
Dietary pattern, diet quality, and dementia: a systematic review and meta-analysis of prospective cohort studies
Liu, Y.-H., Gao, X., Na, M., Kris-Etherton, P. M., Mitchell, D. C., & Jensen, G. L. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200499 · Cited by 86
The neutrophil-to-lymphocyte ratio in Alzheimer's disease: Current understanding and potential applications
Sayed, A., Bahbah, E. I., Kamel, S., Barreto, G. E., Ashraf, G. M., & Elfil, M. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577398 · Cited by 88
Near-Infrared Fluorescent Probes as Imaging and Theranostic Modalities for Amyloid-Beta and Tau Aggregates in Alzheimer’s Disease
Rai, H., Gupta, S., Kumar, S., Yang, J., Singh, S. K., Ran, C., & Modi, G. P. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01619 · Cited by 87
The Public Health Road Map to Respond to the Growing Dementia Crisis
Olivari, B. S., French, M. E., & McGuire, L. C. (2020) · Innovation in Aging · doi:10.1093/geroni/igz043 · Cited by 84
Camellia oil alleviates the progression of Alzheimer's disease in aluminum chloride-treated rats
Weng, M.-H., Chen, S.-Y., Li, Z., & Yen, G. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.04.004 · Cited by 84
A nanocleaner specifically penetrates the blood‒brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer's disease
Lei, T., Yang, Z., Xia, X., Chen, Y., Yang, X., Xie, R., Tong, F., Wang, X., & Gao, H. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.04.022 · Cited by 85
Synaptic dysfunction in early phases of Alzheimer's Disease
Pelucchi, S., Gardoni, F., Luca, M. D., & Marcello, E. E. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819410-2.00022-9 · Cited by 95
Mass Spectrometry Methods for Measuring Protein Stability
Vallejo, D. D., Ramírez, C. R., Parson, K. F., Han, Y., Gadkari, V. V., & Ruotolo, B. T. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00857 · Cited by 88
Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid β
Vogt, A. S., Jennings, G. T., Mohsen, M. O., Vogel, M., & Bachmann, M. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043895 · Cited by 88
Sex-dependent effect of APOE on Alzheimer's disease and other age-related neurodegenerative disorders
Gamache, J., Yun, Y., & Chiba-Falek, O. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.045211 · Cited by 84
Pharmaceutical Treatment for Alzheimer’s Disease and Related Dementias: Utilization and Disparities
Barthold, D., Joyce, G., Ferido, P., Drabo, E. F., Marcum, Z. A., Gray, S. L., & Zissimopoulos, J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200133 · Cited by 85
Trends in the Risk of Cognitive Impairment in the United States, 1996–2014
Hale, J. M., Schneider, D. C., Gampe, J., Mehta, N. K., & Myrskylä, M. (2020) · Epidemiology · doi:10.1097/ede.0000000000001219 · Cited by 86
The Potential Contribution of Chronic Pain and Common Chronic Pain Conditions to Subsequent Cognitive Decline, New Onset Cognitive Impairment, and Incident Dementia: A Systematic Review and Conceptual Model for Future Research
Innes, K. E., & Sambamoorthi, U. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200960 · Cited by 87
Copper Imbalance in Alzheimer’s Disease: Meta-Analysis of Serum, Plasma, and Brain Specimens, and Replication Study Evaluating ATP7B Gene Variants
Squitti, R., Ventriglia, M., Simonelli, I., Bonvicini, C., Costa, A. C., Perini, G., Binetti, G. G., Benussi, L., Ghidoni, R., Koch, G., et al. (2021) · Biomolecules · doi:10.3390/biom11070960 · Cited by 84
Gut dysbiosis and age-related neurological diseases; an innovative approach for therapeutic interventions
Holmes, A., Finger, C. E., Morales‐Scheihing, D., Lee, J., & McCullough, L. D. (2020) · Translational research · doi:10.1016/j.trsl.2020.07.012 · Cited by 88
Are mitophagy enhancers therapeutic targets for Alzheimer’s disease?
Pradeepkiran, J. A., Hindle, A., Kshirsagar, S., & Reddy, P. H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112918 · Cited by 83
Transfer learning for predicting conversion from mild cognitive impairment to dementia of Alzheimer's type based on a three-dimensional convolutional neural network
(2020) · doi:10.1016/j.neurobiolaging.2020.12.005 · Cited by 78
Transformed domain convolutional neural network for Alzheimer's disease diagnosis using structural MRI
Abbas, S. Q., Chi, L., & Chen, Y. P. (2022) · Pattern Recognition · doi:10.1016/j.patcog.2022.109031 · Cited by 85
“Alzheimer’s disease (AD) is one of the most common type of neurodegenerative dementia that primarily impairs the function of brain neurons and its subsequent progression hampers cognitive reasoning [1] .”
Influential
Preclinical Models for Alzheimer’s Disease: Past, Present, and Future Approaches
Akhtar, A., Gupta, S. M., Dwivedi, S., Kumar, D., Shaikh, M. F., & Negi, A. (2022) · ACS Omega · doi:10.1021/acsomega.2c05609 · Cited by 85
Eye-tracking paradigms for the assessment of mild cognitive impairment: a systematic review
Wolf, A., Tripanpitak, K., Umeda, S., & Otake, M. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1197567 · Cited by 92
Can exercise training teach us how to treat Alzheimer's disease?
Huuha, A. M., Norevik, C. S., Moreira, J. B. N., Kobro-Flatmoen, A., Scrimgeour, N., Kivipelto, M., Van Praag, H., Ziaei, M., Sando, S. B., Wisløff, U., et al. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101559 · Cited by 79
“Alzheimer’s disease (AD) is a progressive neurodegenerative disease that accounts for 60–80% of all dementia cases (Association, 2019).”
Piezoelectric materials for ultrasound-driven dissociation of Alzheimer's β-amyloid aggregate structure
Jang, J., Kim, K., Yoon, J., & Park, C. B. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120165 · Cited by 80
Artificial Intelligence for Caregivers of Persons With Alzheimer’s Disease and Related Dementias: Systematic Literature Review
Xie, B., Tao, C., Li, J., Hilsabeck, R. C., & Aguirre, A. (2020) · JMIR Medical Informatics · doi:10.2196/18189 · Cited by 80
Hazed and Confused: The Effect of Air Pollution on Dementia
Bishop, K. C., Ketcham, J. D., & Kuminoff, N. V. (2018) · National Bureau of Economic Research · doi:10.3386/w24970 · Cited by 84
Subjective cognitive decline higher among sexual and gender minorities in the United States, 2015–2018
Flatt, J. D., Cicero, E. C., Lambrou, N. H., Wharton, W., Anderson, J. G., Bouldin, E. D., McGuire, L. C., & Taylor, C. A. (2021) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12197 · Cited by 78
Sex Differences in Cardiovascular Disease and Cognitive Impairment: Another Health Disparity for Women?
Volgman, A. S., Merz, C. N. B., Aggarwal, N. T., Bittner, V., Bunch, T. J., Gorelick, P. B., Maki, P. M., Patel, H. N., Poppas, A., Ruskin, J. N., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013154 · Cited by 82
The Application of Artificial Intelligence in the Genetic Study of Alzheimer’s Disease
Mishra, R., & Li, B. (2020) · Aging and Disease · doi:10.14336/ad.2020.0312 · Cited by 85
Themes describing social isolation in family caregivers of people living with dementia: A scoping review
Lee, J., Baik, S., Becker, T. D., & Cheon, J. H. (2022) · Dementia · doi:10.1177/14713012211056288 · Cited by 78
Identification of Conserved Proteomic Networks in Neurodegenerative Dementia
Swarup, V., Chang, T. S., Duong, D. M., Dammer, E. B., Dai, J., Lah, J. J., Johnson, E. C. B., Seyfried, N. T., Levey, A. I., & Geschwind, D. H. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107807 · Cited by 78
Amyloid-β and p-Tau Anti-Threat Response to Herpes Simplex Virus 1 Infection in Primary Adult Murine Hippocampal Neurons
Powell, R. D., Abbott, A. R. N., Nelson, L. A., & Bertke, A. S. (2020) · Journal of Virology · doi:10.1128/jvi.01874-19 · Cited by 79
Essential Oils as a Potential Neuroprotective Remedy for Age-Related Neurodegenerative Diseases: A Review
Rashed, A. A., Rahman, A. Z. A., & Rathi, D.-N. G. (2021) · Molecules · doi:10.3390/molecules26041107 · Cited by 78

Authors: Alzheimer's Association
Corresponding author: Alzheimer's Association
Venue: Alzheimer's & Dementia
Publisher: Wiley
Published: 2019-03
Volume: 15
Issue: 3
Pages: 321-387
ISSN: 1552-5260 (ISSN-L)
1552-5279
DOI: 10.1016/j.jalz.2019.01.010
OpenAlex: W4211139529
Cited by: 2,461
References: 496
Citations by year: 2026: 108 · 2025: 214 · 2024: 245 · 2023: 310 · 2022: 357 · 2021: 558 · 2020: 544 · 2019: 120
FWCI: 316.68
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Alzheimer s & Dementia (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Geriatrics and Gerontology › Geriatric Care and Nursing Homes
Keywords: Alzheimer's disease, dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

2019 Alzheimer’s disease facts and figures.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks